Linker Information
General Information of This Linker
Linker ID |
LIN0IJZUH
|
|||||
---|---|---|---|---|---|---|
Linker Name |
Mal-Pro-D-Lys
|
|||||
Linker Type |
Cathepsin-cleavable linker
|
|||||
Antibody-Linker Relation |
Cleavable
|
|||||
Structure | ||||||
Formula |
C20H32N6O5
|
|||||
Isosmiles |
NCCCCC(N)C(=O)N1CCCC1C(=O)NCCNC(=O)CCN1C(=O)C=CC1=O
|
|||||
InChI |
InChI=1S/C20H32N6O5/c21-9-2-1-4-14(22)20(31)25-12-3-5-15(25)19(30)24-11-10-23-16(27)8-13-26-17(28)6-7-18(26)29/h6-7,14-15H,1-5,8-13,21-22H2,(H,23,27)(H,24,30)
|
|||||
InChIKey |
KWFKNDBTVMWHKI-UHFFFAOYSA-N
|
|||||
Pharmaceutical Properties |
Molecule Weight
|
436.513
|
Polar area
|
167.93
|
||
Complexity
|
31
|
xlogp Value
|
-2.0188
|
|||
Heavy Count
|
31
|
Rot Bonds
|
12
|
|||
Hbond acc
|
7
|
Hbond Donor
|
4
|
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
1F6-Pro- (D)Lys-AF [Investigative]
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | > 10.00 uM | Positive TNF expression (TNF+++/++) | ||
Method Description |
IC50 values are the mean and SD of 21 independent experimental titrations, each performed at least in duplicate.
|
||||
In Vitro Model | Renal cell carcinoma | 786-O cells | CVCL_1051 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | > 10.00 uM | Positive TNF expression (TNF+++/++) | ||
Method Description |
IC50 values are the mean and SD of 21 independent experimental titrations, each performed at least in duplicate.
|
||||
In Vitro Model | Clear cell renal cell carcinoma | Caki-1 cells | CVCL_0234 | ||
Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | > 10.00 uM | Positive TNF expression (TNF+++/++) | ||
Method Description |
IC50 values are the mean and SD of 21 independent experimental titrations, each performed at least in duplicate.
|
||||
In Vitro Model | Hodgkin lymphoma | L-428 cells | CVCL_1361 |
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.